The International Congress on Neuromuscular Diseases (ICNMD) returns online on 20–21 November 2025, bringing together leading experts and clinicians from around the world. This two-day event provides a unique opportunity to connect globally, explore cutting-edge neuromuscular research, and exchange knowledge that will shape future care and therapies.
The program features sessions on muscle disorders, peripheral neuropathies, neuromuscular transmission disorders, and motor neuron diseases. Highlights include Prof. Nicolas Deconinck on innovative therapies in myositis, Dr. Roser Velasco on biomarkers for chemotherapy-induced neuropathy, Dr. Shahar Shelly on targeted therapies in myasthenia gravis crises, and Prof. Philip van Damme on ALS phenotypes. Each session will provide fresh insights into diagnosis, treatment, and the latest therapeutic developments.
Designed for clinicians, researchers, and healthcare professionals, ICNMDigital 2025 offers a focused, accessible platform to stay up to date with advances in neuromuscular medicine. Attendees will benefit from interactive discussions, expert-led lectures, and the chance to network with peers worldwide.
Don’t miss your opportunity to take part. Registration is now open at ICNMDigital 2025. Secure your place today and join the global neuromuscular community this November.
Program details at https://icnmd.org/icnmdigital-2025/
Register today a https://icsevents.eventsair.com/icnmdigital2025/reg
ICNMDigital Secretariat
International Conference Services (ICS)
Email: icnmd@icsevents.com
Web: icsevents.com
Web design by Tribal Systems